Independent Pharmacy Insights

NASP: Calling Out DIR Fees and PBM Complicity

The National Association of Specialty Pharmacy (NASP) made a bold and decisive move by stating its position on specialty drug pricing’s two most controversial issues – DIR Fees and PBM Complicity. The NASP believes that the lack of transparency in...

09 / 28 / 2017 Read More

DIR Fees and the Importance of Alliances to Drive Transparency and Save Costs

There are many unique challenges to running profitable independent pharmacies.  One challenge that can have a negative impact is an independent pharmacy’s dealings with pharmacy benefit managers (PBMs).  Unlike larger retail pharmacies, which have a...

03 / 15 / 2017 Read More

Why DIR Fees are causing problems and what is being done

Direct and Indirect Remuneration (also known as DIR Fees) (1) are complicated. They are even more complicated when they are imposed on independent pharmacies by prescription drug plan sponsors, their intermediaries and pharmacy benet managers (PBMs)....

10 / 11 / 2016 Read More

What are DIR Fees and why do they Matter?

As we all know, one of the top challenges every small business faces is managing cash flow (1). After all, unpredictable cash flow can throw a wrench into an organization’s ability to pay utilities, staff, and vendors. Financial obligations won’t...

10 / 11 / 2016 Read More
Get a competitive advantage

Independent pharmacies rely on alliantRx for increasing profits and maintaining a competitive advantage against chain pharmacies. Shouldn't you?

Learn More